TY - JOUR AU - Brantley, S. J. AU - Argikar, A. A. AU - Lin, Y. S. AU - Nagar, S. AU - Paine, M. F. PY - 2014 DA - 2014// TI - Herb-drug interactions: challenges and opportunities for improved predictions JO - Drug Metab Dispos VL - 42 ID - Brantley2014 ER - TY - JOUR AU - Fasinu, P. S. AU - Bouic, P. J. AU - Rosenkranz, B. PY - 2012 DA - 2012// TI - An overview of the evidence and mechanisms of herb-drug interactions JO - Front Pharmacol VL - 3 ID - Fasinu2012 ER - TY - JOUR AU - Wu, Y. S. AU - Lee, Z. Y. AU - Chuah, L. H. AU - Mai, C. W. AU - Ngai, S. C. PY - 2019 DA - 2019// TI - Epigenetics in metastatic breast cancer: its regulation and implications in diagnosis, prognosis and therapeutics JO - Curr Cancer Drug Targets VL - 19 ID - Wu2019 ER - TY - JOUR AU - Mai, C. W. AU - Chung, F. F. AU - Leong, C. O. PY - 2017 DA - 2017// TI - Targeting Legumain as a novel therapeutic strategy in cancers JO - Curr Drug Targets VL - 18 ID - Mai2017 ER - TY - JOUR AU - Chung, F. F. AU - Mai, C. W. AU - Ng, P. Y. AU - Leong, C. O. PY - 2016 DA - 2016// TI - Cytochrome P450 2W1 (CYP2W1) in colorectal cancers JO - Curr Cancer Drug Targets VL - 16 ID - Chung2016 ER - TY - JOUR AU - Tham, S. Y. AU - Loh, H. S. AU - Mai, C. W. AU - Fu, J. Y. PY - 2019 DA - 2019// TI - Tocotrienols modulate a life or death decision in cancers JO - Int J Mol Sci VL - 20 ID - Tham2019 ER - TY - JOUR AU - Krishnan, P. r. e. m. a. n. a. n. d. AU - Lee, F. o. n. g. -. K. a. i. AU - Chong, K. a. m. -. W. e. n. g. AU - Mai, C. h. u. n. -. W. a. i. AU - Muhamad, A. z. i. r. a. AU - Lim, S. i. e. w. -. H. u. a. h. AU - Low, Y. u. n. -. Y. e. e. AU - Ting, K. a. n. g. -. N. e. e. AU - Lim, K. u. a. n. -. H. o. n. PY - 2018 DA - 2018// TI - Alstoscholactine and Alstolaxepine, Monoterpenoid Indole Alkaloids with γ-Lactone-Bridged Cycloheptane and Oxepane Moieties from Alstonia scholaris JO - Organic Letters VL - 20 ID - Krishnan2018 ER - TY - JOUR AU - Krishnan, P. AU - Mai, C. W. AU - Yong, K. T. AU - Low, Y. Y. AU - Lim, K. H. PY - 2019 DA - 2019// TI - Alstobrogaline, an unusual pentacyclic monoterpenoid indole alkaloid with aldimine and aldimine-N-oxide moieties from Alstonia scholaris JO - Tetrad Lett VL - 60 ID - Krishnan2019 ER - TY - JOUR AU - Al-Khdhairawi, A. A. Q. AU - Krishnan, P. AU - Mai, C. W. AU - Chung, F. F. AU - Leong, C. O. AU - Yong, K. T. PY - 2017 DA - 2017// TI - A Bis-benzopyrroloisoquinoline alkaloid incorporating a Cyclobutane Core and a Chlorophenanthroindolizidine alkaloid with cytotoxic activity from Ficus fistulosa var. tengerensis JO - J Nat Prod VL - 80 ID - Al-Khdhairawi2017 ER - TY - STD TI - Chung FF, Tan PF, Raja VJ, Tan BS, Lim KH, Kam TS, et al. Jerantinine a induces tumor-specific cell death through modulation of splicing factor 3b subunit 1 (SF3B1). Sci Rep. 2017;7:42504. https://doi.org/10.1038/srep42504. ID - ref10 ER - TY - JOUR AU - Soo, H. C. AU - Chung, F. F. AU - Lim, K. H. AU - Yap, V. A. AU - Bradshaw, T. D. AU - Hii, L. W. PY - 2017 DA - 2017// TI - Cudraflavone C induces tumor-specific apoptosis in colorectal cancer cells through inhibition of the phosphoinositide 3-kinase (PI3K)-AKT pathway JO - PLoS One VL - 12 ID - Soo2017 ER - TY - JOUR AU - Krishnan, P. AU - Mai, C. -. W. AU - Yong, K. -. T. AU - Low, Y. -. Y. AU - Lim, K. -. H. PY - 2019 DA - 2019// TI - Alstobrogaline, an unusual pentacyclic monoterpenoid indole alkaloid with aldimine and aldimine-N-oxide moieties from Alstonia scholaris JO - Tetrahedron Lett VL - 60 ID - Krishnan2019 ER - TY - JOUR AU - Sakdarat, S. AU - Shuyprom, A. AU - Pientong, C. AU - Ekalaksananan, T. AU - Thongchai, S. PY - 2009 DA - 2009// TI - Bioactive constituents from the leaves of Clinacanthus nutans Lindau JO - Bioorg Med Chem VL - 17 ID - Sakdarat2009 ER - TY - JOUR AU - Charuwichitratana, S. AU - Wongrattanapasson, N. AU - Timpatanapong, P. AU - Bunjob, M. PY - 1996 DA - 1996// TI - Herpes zoster: treatment with Clinacanthus nutans cream JO - Int J Dermatol VL - 35 ID - Charuwichitratana1996 ER - TY - JOUR AU - Yong, Y. K. AU - Tan, J. J. AU - Teh, S. S. AU - Mah, S. H. AU - Ee, G. C. AU - Chiong, H. S. PY - 2013 DA - 2013// TI - Clinacanthus nutans extracts are antioxidant with Antiproliferative effect on cultured human cancer cell lines JO - Evid Based Complement Alternat Med VL - 2013 ID - Yong2013 ER - TY - JOUR AU - Liew, S. Y. AU - Stanbridge, E. J. AU - Yusoff, K. AU - Shafee, N. PY - 2012 DA - 2012// TI - Hypoxia affects cellular responses to plant extracts JO - J Ethnopharmacol VL - 144 ID - Liew2012 ER - TY - JOUR AU - Houghton, P. AU - Fang, R. AU - Techatanawat, I. AU - Steventon, G. AU - Hylands, P. J. AU - Lee, C. C. PY - 2007 DA - 2007// TI - The sulphorhodamine (SRB) assay and other approaches to testing plant extracts and derived compounds for activities related to reputed anticancer activity JO - Methods. VL - 42 ID - Houghton2007 ER - TY - JOUR AU - Mai, C. W. AU - Yap, K. S. AU - Kho, M. T. AU - Ismail, N. H. AU - Yusoff, K. AU - Shaari, K. PY - 2016 DA - 2016// TI - Mechanisms underlying the anti-inflammatory effects of Clinacanthus nutans Lindau extracts: inhibition of cytokine production and toll-like Receptor-4 activation JO - Front Pharmacol VL - 7 ID - Mai2016 ER - TY - JOUR AU - Tan, B. S. AU - Kang, O. AU - Mai, C. W. AU - Tiong, K. H. AU - Khoo, A. S. AU - Pichika, M. R. PY - 2013 DA - 2013// TI - 6-Shogaol inhibits breast and colon cancer cell proliferation through activation of peroxisomal proliferator activated receptor gamma (PPARgamma) JO - Cancer Lett VL - 336 ID - Tan2013 ER - TY - JOUR AU - Mai, C. W. AU - Kang, Y. B. AU - Nadarajah, V. D. AU - Hamzah, A. S. AU - Pichika, M. R. PY - 2018 DA - 2018// TI - Drug-like dietary vanilloids induce anticancer activity through proliferation inhibition and regulation of bcl-related apoptotic proteins JO - Phytother Res VL - 32 ID - Mai2018 ER - TY - JOUR AU - Yeong, K. Y. AU - Tan, S. C. AU - Mai, C. W. AU - Leong, C. O. AU - Chung, F. F. AU - Lee, Y. K. PY - 2018 DA - 2018// TI - Contrasting sirtuin and poly (ADP-ribose) polymerase activities of selected 2,4,6-trisubstituted benzimidazoles JO - Chem Biol Drug Des VL - 91 ID - Yeong2018 ER - TY - JOUR AU - Mai, C. W. AU - Yaeghoobi, M. AU - Abd-Rahman, N. AU - Kang, Y. B. AU - Pichika, M. R. PY - 2014 DA - 2014// TI - Chalcones with electron-withdrawing and electron-donating substituents: anticancer activity against TRAIL resistant cancer cells, structure-activity relationship analysis and regulation of apoptotic proteins JO - Eur J Med Chem VL - 77 ID - Mai2014 ER - TY - JOUR AU - Chung, F. F. AU - Tan, P. F. AU - Raja, V. J. AU - Tan, B. S. AU - Lim, K. H. AU - Kam, T. S. PY - 2017 DA - 2017// TI - Jerantinine a induces tumor-specific cell death through modulation of splicing factor 3b subunit 1 (SF3B1) JO - Sci Rep VL - 7 ID - Chung2017 ER - TY - JOUR AU - Chou, T. C. AU - Talalay, P. PY - 1984 DA - 1984// TI - Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors JO - Adv Enzym Regul VL - 22 ID - Chou1984 ER - TY - JOUR AU - Er, J. L. AU - Goh, P. N. AU - Lee, C. Y. AU - Tan, Y. J. AU - Hii, L. W. AU - Mai, C. W. PY - 2018 DA - 2018// TI - Identification of inhibitors synergizing gemcitabine sensitivity in the squamous subtype of pancreatic ductal adenocarcinoma (PDAC) JO - Apoptosis. VL - 23 ID - Er2018 ER - TY - JOUR AU - Low, S. Y. AU - Tan, B. S. AU - Choo, H. L. AU - Tiong, K. H. AU - Khoo, A. S. AU - Leong, C. O. PY - 2012 DA - 2012// TI - Suppression of BCL-2 synergizes cisplatin sensitivity in nasopharyngeal carcinoma cells JO - Cancer Lett VL - 314 ID - Low2012 ER - TY - JOUR AU - Wong, S. W. AU - Tiong, K. H. AU - Kong, W. Y. AU - Yue, Y. C. AU - Chua, C. H. AU - Lim, J. Y. PY - 2011 DA - 2011// TI - Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73 JO - Breast Cancer Res Treat VL - 128 ID - Wong2011 ER - TY - JOUR AU - Chou, T. C. PY - 2006 DA - 2006// TI - Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies JO - Pharmacol Rev VL - 58 ID - Chou2006 ER - TY - JOUR AU - Veroli, G. Y. AU - Fornari, C. AU - Wang, D. AU - Mollard, S. AU - Bramhall, J. L. AU - Richards, F. M. PY - 2016 DA - 2016// TI - Combenefit: an interactive platform for the analysis and visualization of drug combinations JO - Bioinformatics. VL - 32 ID - Veroli2016 ER - TY - JOUR AU - Greco, W. R. AU - Bravo, G. AU - Parsons, J. C. PY - 1995 DA - 1995// TI - The search for synergy: a critical review from a response surface perspective JO - Pharmacol Rev VL - 47 ID - Greco1995 ER - TY - JOUR AU - Keith, C. T. AU - Borisy, A. A. AU - Stockwell, B. R. PY - 2005 DA - 2005// TI - Multicomponent therapeutics for networked systems JO - Nat Rev Drug Discov VL - 4 ID - Keith2005 ER - TY - JOUR AU - Prichard, M. N. AU - Shipman, C. PY - 1990 DA - 1990// TI - A three-dimensional model to analyze drug-drug interactions JO - Antivir Res VL - 14 ID - Prichard1990 ER - TY - JOUR AU - Eisenberg, D. M. AU - Davis, R. B. AU - Ettner, S. L. AU - Appel, S. AU - Wilkey, S. AU - Rompay, M. PY - 1998 DA - 1998// TI - Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey JO - JAMA. VL - 280 ID - Eisenberg1998 ER - TY - JOUR AU - Engel, L. W. AU - Straus, S. E. PY - 2002 DA - 2002// TI - Development of therapeutics: opportunities within complementary and alternative medicine JO - Nat Rev Drug Discov VL - 1 ID - Engel2002 ER - TY - JOUR AU - Astin, J. A. PY - 1998 DA - 1998// TI - Why patients use alternative medicine: results of a national study JO - JAMA. VL - 279 ID - Astin1998 ER - TY - JOUR AU - Johnson, S. B. AU - Park, H. S. AU - Gross, C. P. AU - Yu, J. B. PY - 2018 DA - 2018// TI - Complementary medicine, refusal of conventional cancer therapy, and survival among patients with curable cancers JO - JAMA Oncol VL - 4 ID - Johnson2018 ER - TY - JOUR AU - Richardson, M. A. AU - Sanders, T. AU - Palmer, J. L. AU - Greisinger, A. AU - Singletary, S. E. PY - 2000 DA - 2000// TI - Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology JO - J Clin Oncol VL - 18 ID - Richardson2000 ER - TY - JOUR AU - Dy, G. K. AU - Bekele, L. AU - Hanson, L. J. AU - Furth, A. AU - Mandrekar, S. AU - Sloan, J. A. PY - 2004 DA - 2004// TI - Complementary and alternative medicine use by patients enrolled onto phase I clinical trials JO - J Clin Oncol VL - 22 ID - Dy2004 ER - TY - JOUR AU - Vapiwala, N. AU - Mick, R. AU - Hampshire, M. K. AU - Metz, J. M. AU - DeNittis, A. S. PY - 2006 DA - 2006// TI - Patient initiation of complementary and alternative medical therapies (CAM) following cancer diagnosis JO - Cancer J VL - 12 ID - Vapiwala2006 ER - TY - JOUR AU - Looi, C. K. AU - Chung, F. F. L. AU - Leong, C. O. AU - Wong, S. F. AU - Rosli, R. AU - Mai, C. W. PY - 2019 DA - 2019// TI - Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment JO - J Exp Clin Cancer Res VL - 38 ID - Looi2019 ER - TY - JOUR AU - Zulkipli, I. N. AU - Rajabalaya, R. AU - Idris, A. AU - Sulaiman, N. A. AU - David, S. R. PY - 2017 DA - 2017// TI - Clinacanthus nutans: a review on ethnomedicinal uses, chemical constituents and pharmacological properties JO - Pharm Biol VL - 55 ID - Zulkipli2017 ER - TY - JOUR AU - Khoo, L. W. AU - Audrey Kow, S. AU - Lee, M. T. AU - Tan, C. P. AU - Shaari, K. AU - Tham, C. L. PY - 2018 DA - 2018// TI - A comprehensive review on Phytochemistry and pharmacological activities of Clinacanthus nutans (Burm.F.) Lindau JO - Evid Based Complement Alternat Med VL - 2018 ID - Khoo2018 ER - TY - JOUR AU - Bailey, P. AU - Chang, D. K. AU - Nones, K. AU - Johns, A. L. AU - Patch, A. M. AU - Gingras, M. C. PY - 2016 DA - 2016// TI - Genomic analyses identify molecular subtypes of pancreatic cancer JO - Nature. VL - 531 ID - Bailey2016 ER - TY - JOUR AU - Camolotto, S. A. AU - Belova, V. K. AU - Snyder, E. L. PY - 2018 DA - 2018// TI - The role of lineage specifiers in pancreatic ductal adenocarcinoma JO - J Gastrointest Oncol VL - 9 ID - Camolotto2018 ER - TY - JOUR AU - Eriksson, E. AU - Wenthe, J. AU - Irenaeus, S. AU - Loskog, S. AU - Ullenhag, G. PY - 2016 DA - 2016// TI - Gemcitabine reduces MDSCs, tregs and TGFβ-1 while restoring the teff/treg ratio in patients with pancreatic cancer JO - J Transl Med VL - 14 ID - Eriksson2016 ER - TY - JOUR AU - Kim, N. AU - Kang, M. J. AU - Lee, S. H. AU - Son, J. H. AU - Lee, J. E. AU - Paik, W. H. PY - 2018 DA - 2018// TI - Fisetin enhances the cytotoxicity of gemcitabine by down-regulating ERK-MYC in MiaPaca-2 human pancreatic cancer cells JO - Anticancer Res VL - 38 ID - Kim2018 ER - TY - JOUR AU - Grippo, P. J. PY - 2018 DA - 2018// TI - Pancreatic cancer subtypes: a roadmap for precision medicine AU - Torres, Carolina JO - Ann Med VL - 50 ID - Grippo2018 ER - TY - JOUR AU - Yu, J. AU - Drisko, J. AU - Chen, Q. PY - 2013 DA - 2013// TI - Inhibition of pancreatic cancer and potentiation of gemcitabine effects by the extract of Pao Pereira JO - Oncol Rep VL - 30 ID - Yu2013 ER - TY - JOUR AU - Yu, J. AU - Chen, Q. PY - 2014 DA - 2014// TI - Antitumor activities of Rauwolfia vomitoria extract and potentiation of gemcitabine effects against pancreatic cancer JO - Integr Cancer Ther VL - 13 ID - Yu2014 ER - TY - JOUR AU - Pandita, A. AU - Kumar, B. AU - Manvati, S. AU - Vaishnavi, S. AU - Singh, S. K. AU - Bamezai, R. N. K. PY - 2014 DA - 2014// TI - Synergistic combination of gemcitabine and dietary molecule induces apoptosis in pancreatic cancer cells and down regulates PKM2 expression JO - PLoS One VL - 9 ID - Pandita2014 ER - TY - JOUR AU - Laar, E. S. AU - Roth, S. AU - Weitman, S. AU - Macdonald, J. R. AU - Waters, S. J. PY - 2004 DA - 2004// TI - Activity of Irofulven against human pancreatic carcinoma cell lines in vitro and in vivo JO - Anticancer Res VL - 24 ID - Laar2004 ER - TY - JOUR AU - Yue, Q. AU - Gao, G. AU - Zou, G. AU - Yu, H. AU - Zheng, X. PY - 2017 DA - 2017// TI - Natural products as adjunctive treatment for pancreatic cancer: recent trends and advancements JO - Biomed Res Int VL - 2017 ID - Yue2017 ER - TY - JOUR AU - Venat-Bouvet, L. AU - Ly, K. AU - Szelag, J. C. AU - Martin, J. AU - Labourey, J. L. AU - Genet, D. PY - 2003 DA - 2003// TI - Thrombotic microangiopathy and digital necrosis: two unrecognized toxicities of gemcitabine JO - Anti-Cancer Drugs VL - 14 ID - Venat-Bouvet2003 ER - TY - JOUR AU - Teusink, A. C. AU - Hall, P. D. PY - 2010 DA - 2010// TI - Toxicities of gemcitabine in patients with severe hepatic dysfunction JO - Ann Pharmacother VL - 44 ID - Teusink2010 ER - TY - JOUR AU - Matsubara, J. AU - Ono, M. AU - Negishi, A. AU - Ueno, H. AU - Okusaka, T. AU - Furuse, J. PY - 2009 DA - 2009// TI - Identification of a predictive biomarker for hematologic toxicities of gemcitabine JO - J Clin Oncol VL - 27 ID - Matsubara2009 ER - TY - JOUR AU - Maniam, G. AU - Mai, C. W. AU - Zulkefeli, M. AU - Dufes, C. AU - Tan, D. M. AU - Fu, J. Y. PY - 2018 DA - 2018// TI - Challenges and opportunities of nanotechnology as delivery platform for Tocotrienols in cancer therapy JO - Front Pharmacol VL - 9 ID - Maniam2018 ER - TY - JOUR AU - Sharma, J. AU - Srinivasan, R. AU - Majumdar, S. AU - Mir, S. AU - Radotra, B. D. AU - Wig, J. D. PY - 2005 DA - 2005// TI - Bcl-XL protein levels determine apoptotic index in pancreatic carcinoma JO - Pancreas. VL - 30 ID - Sharma2005 ER - TY - JOUR AU - Ferrandina, G. AU - Legge, F. AU - Martinelli, E. AU - Ranelletti, F. O. AU - Zannoni, G. F. AU - Lauriola, L. PY - 2005 DA - 2005// TI - Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters JO - Br J Cancer VL - 92 ID - Ferrandina2005 ER - TY - JOUR AU - Mai, C. W. AU - Kang, Y. B. AU - Pichika, M. R. PY - 2013 DA - 2013// TI - Should a toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers JO - Onco Targets Ther VL - 6 ID - Mai2013 ER - TY - JOUR AU - Vaz, J. AU - Andersson, R. PY - 2014 DA - 2014// TI - Intervention on toll-like receptors in pancreatic cancer JO - World J Gastroenterol VL - 20 ID - Vaz2014 ER -